Microstructure Imaging Wins FDA Clearance for MICSI-PET on September 16, 2026 Amyloid Centiloid Clearance Microstructure Imaging MICSI-PET MRI-guided enhancement neurological imaging Positron-Emission Tomography United States Food and Drug Administration uridine triacetate +
Roche, Eli Lilly Alzheimer’s Blood Test Gets FDA Clearance on August 25, 2026 Amyloid blood biomarker test Clearance Elecsys pTau217 eli lilly Pathology phosphorylated Quest Diagnostics Roche (company) United States Food and Drug Administration uridine triacetate +
Biogen's Tau-Targeting Alzheimer's Drug Shows Promising but Confusing Results on July 24, 2026 Alzheimer 's disease BIIB080 Biogen CELIA Clinical Research diranersen Mental deterioration Phase 3 trials tau-targeting drug uridine triacetate +
AAIC 2026：Biogen公布抗tau反义寡核苷酸药物详细数据，抗tau领域初现曙光 on July 15, 2026 AAIC Biogen diranersen Pet Animal uridine triacetate +
Questions linger over Biogen's tau drug for Alzheimer's, as low dose reports better results on July 15, 2026 Alzheimer 's disease Biogen CDR-SB CELIA Phase 2 trial diranersen dose-response Low dose Mental deterioration Pathology Phase 3 questions uridine triacetate +
Biogen advances anti-tau Alzheimer’s drug diranersen despite mixed Phase 2 results on May 15, 2026 Alzheimer 's disease Biogen CELIA diranersen Ionis Pharmaceuticals Mental deterioration Phase 2 trial registrational development uridine triacetate +
Biogen advances Alzheimer’s tau program despite midphase miss on May 14, 2026 Benefit Biogen Biological Markers Cognitive diranersen Phase 2 Phase 3 registrational development uridine triacetate +